| 1 |
33938943 | G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor-mediated cell death. | 2021 May 11 |
1 |
| 2 |
32235770 | Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors. | 2020 Mar 22 |
3 |
| 3 |
32724371 | Effect of bortezomib on proliferation and apoptosis of myeloma cells by activating Wnt/β-catenin signaling pathway. | 2020 Aug |
1 |
| 4 |
33099868 | Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYC. | 2020 Dec |
2 |
| 5 |
30837032 | Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway. | 2019 Jun 21 |
2 |
| 6 |
31406244 | FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma. | 2019 Oct |
1 |
| 7 |
29472861 | 1,2,3,4,6-Penta-O-Galloyl-Beta-D-Glucopyranoside Inhibits Proliferation of Multiple Myeloma Cells Accompanied with Suppression of MYC Expression. | 2018 |
1 |
| 8 |
28000897 | Bortezomib induces apoptosis and suppresses cell growth and metastasis by inactivation of Stat3 signaling in chondrosarcoma. | 2017 Feb |
1 |
| 9 |
26667773 | Comparison of antiproliferative and apoptotic effects of a novel proteasome inhibitor MLN2238 with bortezomib on K562 chronic myeloid leukemia cells. | 2016 |
2 |
| 10 |
26683226 | MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment. | 2016 Jan 26 |
1 |
| 11 |
26740054 | Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells. | 2016 Feb |
2 |
| 12 |
26317903 | Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression. | 2015 Sep 22 |
3 |
| 13 |
26378933 | Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma. | 2015 |
1 |
| 14 |
24104394 | MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma. | 2014 Apr |
2 |
| 15 |
24496825 | Impact of C-Myc gene-related aberrations in newly diagnosed myeloma with bortezomib/dexamethasone therapy. | 2014 Mar |
1 |
| 16 |
25147211 | MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib. | 2014 |
2 |
| 17 |
23527180 | cMyc/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomas. | 2013 |
3 |
| 18 |
23536725 | Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model. | 2013 Jun |
1 |
| 19 |
23612979 | Mammalian target of rapamycin complex 1 (mTORC1) enhances bortezomib-induced death in tuberous sclerosis complex (TSC)-null cells by a c-MYC-dependent induction of the unfolded protein response. | 2013 May 31 |
3 |
| 20 |
21297663 | Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. | 2011 Jun 2 |
1 |
| 21 |
21468039 | Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma. | 2011 Jun |
1 |
| 22 |
20460535 | Genome-wide siRNA screen for modulators of cell death induced by proteasome inhibitor bortezomib. | 2010 Jun 1 |
1 |
| 23 |
20615981 | Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma. | 2010 Jul 20 |
1 |
| 24 |
18235046 | PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor. | 2008 Apr 1 |
1 |
| 25 |
18544564 | Hypoxia-inducible factor-2alpha regulates the expression of TRAIL receptor DR5 in renal cancer cells. | 2008 Sep |
3 |
| 26 |
18641367 | Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA. | 2008 Oct 1 |
8 |
| 27 |
18042711 | Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. | 2007 Dec 4 |
1 |